Genmab A/S Cost Of Sales
Genmab A/S (GNMSF) reported Cost Of Sales of $238.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-02-17
- Genmab A/S cost of sales for the quarter ending 2024-06-30 was 190.00M DKK, a 804.76% increase year-over-year.
- Genmab A/S cost of sales for the quarter ending 2023-06-30 was 21.00M DKK.
DKK
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 12 month |
|---|---|---|---|
| 2024-12-31 | 985.00M DKK 6-K · filed 2025-02-12 | ||
| 2024-06-30 | 190.00M DKK 6-K · filed 2024-08-08 | 375.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 226.00M DKK 6-K · filed 2025-02-12 | ||
| 2023-06-30 | 21.00M DKK 6-K · filed 2024-08-08 | 21.00M DKK 6-K · filed 2024-08-08 |
USD
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 12 month |
|---|---|---|---|
| 2025-12-31 | $238.00M 20-F · filed 2026-02-17 | ||
| 2025-06-30 | $57.00M 6-K · filed 2025-08-07 | $99.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $143.00M 20-F · filed 2026-02-17 | ||
| 2024-06-30 | $28.00M 6-K · filed 2025-08-07 | $55.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $33.00M 20-F · filed 2026-02-17 |